Eugene T Richardson, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemorrhagic Fever, Ebola | 13 | 2020 | 394 | 4.290 |
Why?
|
| Ebolavirus | 6 | 2020 | 252 | 2.060 |
Why?
|
| Disease Outbreaks | 8 | 2020 | 1728 | 1.370 |
Why?
|
| Science | 2 | 2020 | 245 | 0.970 |
Why?
|
| Civil Disorders | 1 | 2020 | 9 | 0.840 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 378 | 0.810 |
Why?
|
| Tuberculosis | 3 | 2016 | 1829 | 0.680 |
Why?
|
| Public Assistance | 1 | 2017 | 45 | 0.660 |
Why?
|
| Africa, Western | 4 | 2019 | 152 | 0.650 |
Why?
|
| Sierra Leone | 5 | 2021 | 153 | 0.610 |
Why?
|
| Carbon Dioxide | 2 | 2016 | 1146 | 0.520 |
Why?
|
| Ventilation | 1 | 2014 | 127 | 0.500 |
Why?
|
| Mining | 1 | 2014 | 87 | 0.500 |
Why?
|
| Vaccines | 1 | 2021 | 735 | 0.470 |
Why?
|
| Loiasis | 1 | 2012 | 2 | 0.470 |
Why?
|
| Isoniazid | 1 | 2014 | 259 | 0.460 |
Why?
|
| Chemoprevention | 1 | 2014 | 314 | 0.440 |
Why?
|
| Eyelid Diseases | 1 | 2012 | 159 | 0.390 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2759 | 0.350 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 416 | 0.350 |
Why?
|
| Pandemics | 2 | 2020 | 7292 | 0.340 |
Why?
|
| Edema | 1 | 2012 | 766 | 0.340 |
Why?
|
| Public Health | 1 | 2020 | 2395 | 0.320 |
Why?
|
| Survivors | 1 | 2017 | 2171 | 0.310 |
Why?
|
| Biomedical Research | 2 | 2014 | 3274 | 0.310 |
Why?
|
| HIV Infections | 5 | 2016 | 15673 | 0.300 |
Why?
|
| Research Personnel | 1 | 2011 | 521 | 0.300 |
Why?
|
| Democratic Republic of the Congo | 3 | 2020 | 86 | 0.300 |
Why?
|
| Travel | 1 | 2012 | 741 | 0.290 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2016 | 1876 | 0.290 |
Why?
|
| Prevalence | 3 | 2021 | 14899 | 0.290 |
Why?
|
| Antitubercular Agents | 1 | 2014 | 1302 | 0.280 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 7733 | 0.280 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 3010 | 0.280 |
Why?
|
| Anti-Retroviral Agents | 1 | 2013 | 1602 | 0.250 |
Why?
|
| Air Pollution | 1 | 2016 | 2024 | 0.240 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3160 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3278 | 0.210 |
Why?
|
| Louisiana | 1 | 2021 | 110 | 0.210 |
Why?
|
| Thailand | 2 | 2019 | 284 | 0.210 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2020 | 177 | 0.180 |
Why?
|
| Republic of Korea | 1 | 2021 | 584 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 8013 | 0.170 |
Why?
|
| Humans | 28 | 2021 | 717280 | 0.160 |
Why?
|
| Human Rights | 2 | 2016 | 259 | 0.160 |
Why?
|
| Social Justice | 1 | 2021 | 421 | 0.150 |
Why?
|
| Quality of Life | 1 | 2017 | 11758 | 0.150 |
Why?
|
| International Educational Exchange | 1 | 2016 | 57 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7486 | 0.140 |
Why?
|
| Panuveitis | 1 | 2015 | 32 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2015 | 161 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 880 | 0.130 |
Why?
|
| Crowding | 1 | 2016 | 146 | 0.130 |
Why?
|
| Poverty Areas | 1 | 2016 | 251 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 211 | 0.130 |
Why?
|
| Bisexuality | 1 | 2016 | 282 | 0.130 |
Why?
|
| Epidemics | 2 | 2016 | 485 | 0.130 |
Why?
|
| Nigeria | 2 | 2016 | 705 | 0.120 |
Why?
|
| Diethylcarbamazine | 1 | 2012 | 28 | 0.120 |
Why?
|
| Filaricides | 1 | 2012 | 10 | 0.120 |
Why?
|
| Violence | 1 | 2019 | 894 | 0.120 |
Why?
|
| Food Supply | 1 | 2018 | 465 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2017 | 821 | 0.110 |
Why?
|
| Health Facilities | 1 | 2016 | 467 | 0.110 |
Why?
|
| South Africa | 1 | 2016 | 1571 | 0.100 |
Why?
|
| Developed Countries | 1 | 2013 | 403 | 0.100 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 523 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 23409 | 0.100 |
Why?
|
| Peer Review | 1 | 2011 | 198 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3968 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2017 | 2547 | 0.090 |
Why?
|
| Viral Proteins | 1 | 2016 | 1976 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2017 | 2535 | 0.090 |
Why?
|
| Homosexuality, Male | 1 | 2016 | 1151 | 0.090 |
Why?
|
| Vision Disorders | 1 | 2015 | 1038 | 0.080 |
Why?
|
| Young Adult | 4 | 2018 | 56249 | 0.080 |
Why?
|
| World Health Organization | 1 | 2013 | 1287 | 0.080 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 1374 | 0.080 |
Why?
|
| Vaccination | 1 | 2019 | 2963 | 0.080 |
Why?
|
| Air Pollution, Indoor | 1 | 2014 | 893 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3567 | 0.070 |
Why?
|
| Adolescent | 4 | 2018 | 85143 | 0.070 |
Why?
|
| Male | 11 | 2020 | 351399 | 0.070 |
Why?
|
| Schools | 1 | 2014 | 1376 | 0.070 |
Why?
|
| Developing Countries | 2 | 2016 | 2732 | 0.070 |
Why?
|
| Students, Medical | 1 | 2016 | 1773 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2014 | 1728 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3902 | 0.060 |
Why?
|
| United States | 3 | 2021 | 67804 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2016 | 4056 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2016 | 4286 | 0.050 |
Why?
|
| Adult | 4 | 2018 | 212470 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 1407 | 0.050 |
Why?
|
| Sex Factors | 1 | 2014 | 10661 | 0.050 |
Why?
|
| Incidence | 2 | 2016 | 20654 | 0.050 |
Why?
|
| Female | 6 | 2018 | 377934 | 0.040 |
Why?
|
| Time | 1 | 2019 | 529 | 0.040 |
Why?
|
| Bolivia | 1 | 2016 | 19 | 0.040 |
Why?
|
| Gambia | 1 | 2016 | 101 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 215054 | 0.040 |
Why?
|
| Legislation as Topic | 1 | 2016 | 85 | 0.040 |
Why?
|
| Russia | 1 | 2016 | 386 | 0.040 |
Why?
|
| Organizations | 1 | 2016 | 164 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1892 | 0.030 |
Why?
|
| Kenya | 1 | 2016 | 564 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19537 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2016 | 554 | 0.030 |
Why?
|
| Viral Load | 1 | 2020 | 3242 | 0.030 |
Why?
|
| India | 1 | 2016 | 2015 | 0.020 |
Why?
|
| China | 1 | 2016 | 2282 | 0.020 |
Why?
|
| International Cooperation | 1 | 2016 | 1420 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2016 | 2599 | 0.020 |
Why?
|
| Minority Groups | 1 | 2016 | 1088 | 0.020 |
Why?
|
| Child | 1 | 2016 | 74388 | 0.020 |
Why?
|
| Leadership | 1 | 2016 | 1343 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2016 | 1910 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 1787 | 0.020 |
Why?
|
| Education, Medical | 1 | 2016 | 1691 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 162862 | 0.020 |
Why?
|
| Health Personnel | 1 | 2016 | 3014 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 4874 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 51277 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 70863 | 0.010 |
Why?
|